Quality of Life Outcomes Following Aortofemoral and Iliofemoral Bypass Surgery in Patients With Peripheral Arterial Disease: A Two-Year Follow-Up Study
- PMID: 38962605
- PMCID: PMC11221623
- DOI: 10.7759/cureus.61598
Quality of Life Outcomes Following Aortofemoral and Iliofemoral Bypass Surgery in Patients With Peripheral Arterial Disease: A Two-Year Follow-Up Study
Abstract
Introduction: Peripheral arterial disease is a circulatory disorder characterized by reduced blood flow to the extremities, predominantly affecting the lower limbs. This study aims to evaluate the impact of aortofemoral and iliofemoral bypass surgeries on patients' quality of life two years post operation and identify predictors of quality-of-life improvements.
Methods: This cross-sectional study included adult patients with aortoiliac disease who underwent bypass surgery (aortofemoral or iliofemoral) at East Jeddah General Hospital from January 2020 to December 2022. Quality of life was assessed using the Arabic version of the Short Form Health Survey 12 (SF-12) preoperatively and two years postoperatively. Data on sociodemographic factors (age, sex, education, income) and medical factors (smoking, BMI, comorbidities) were collected. Statistical analyses included descriptive statistics, t-tests, one-way ANOVA, and regression analyses using IBM SPSS version 25.0 (IBM Corp., Armonk, NY).
Results: The study included 275 patients. Significant improvements in both physical and mental SF-12 scores were observed postoperatively across all patient groups (P < 0.001). Older age, unemployment, and lower income were associated with lower SF-12 scores. Males had higher postoperative mental scores (P = 0.036). Higher BMI and smoking pack-years negatively correlated with SF-12 scores. Patients with comorbidities had significantly lower preoperative and postoperative SF-12 scores (P < 0.05) but showed significant improvements postoperatively (P < 0.001).
Conclusion: Aortofemoral and iliofemoral bypass surgeries significantly improve the quality of life in peripheral arterial disease patients two years post operation. Key predictors of lower quality of life include older age, unemployment, lower income, high BMI, smoking, and comorbidities. Targeted interventions, such as smoking cessation programs, weight management, and comprehensive medical care, are essential for optimizing postoperative outcomes and enhancing patients' physical and mental well-being.
Keywords: aortofemoral bypass; iliofemoral bypass; peripheral arterial disease; quality of life; surgical outcomes.
Copyright © 2024, Alqahtani et al.
Conflict of interest statement
Human subjects: Consent was obtained or waived by all participants in this study. East Jeddah General Hospital issued approval 2020. The study received approval from the institutional review board and ethical committee at the Ministry of Health in Saudi Arabia. Written consent was obtained from all study participants prior to enrollment in the study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
References
-
- The global burden of peripheral artery disease. Eid MA, Mehta K, Barnes JA, et al. J Vasc Surg. 2023;77:1119–1126. - PubMed
-
- Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, Rudan I. Lancet Glob Health. 2019;7:1020–1030. - PubMed
-
- Update on the pathophysiology and medical treatment of peripheral artery disease. Golledge J. Nat Rev Cardiol. 2022;19:456–474. - PubMed
LinkOut - more resources
Full Text Sources